Mumbai-based VAV Lipids has received a certificate of appreciation from United States Pharmacopeia (USP) for its contribution to the standards-setting activities in lipid manufacturing.
United States Pharmacopeia (USP) recognised the efforts of VAV Lipids in providing candidate documentary and reference standards that reached important milestones in 2022. It awarded a Certificate of Appreciation to the company in acknowledgment of the outstanding contribution that it made toward global public health through the advancement of USP standards.
USP’s Certificate of Appreciation noted that VAV Lipids’ contributions have added significant public benefit to the standards-setting process in support of the USP mission, that is, to improve global health through public standards and related programs that help ensure the quality, safety, and benefit of medicines and foods.
VAV Lipids is one of the world’s leading manufacturers of specialised phospholipids for novel drugs and biologics delivery systems (NDDS). Its high-quality lipids are used by pharmaceutical companies to develop multiple projects in drugs and biologics delivery. These include applications of lipids in developing vaccines and formulations, cancer therapy based on liposomes, and novel drug delivery systems for treating several diseases.
